Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic > Biocon Sells 1.88% in Syngene

Biocon Sells 1.88% in Syngene

Chemical Weekly 2018-05-31

Bengaluru-based biotech firm, Biocon, has sold 1.88% stake in its research arm, Syngene International, for around Rs. 230-crore. According to a filing in the exchanges, Biocon sold 37,65,574 equity shares amounting to 1.88% of the equity share capital of Syngene through open market sale. Post the transaction, promoter and promoter group stakes in the company was 72.57%. Also, in a separate filing to the exchanges, Syngene said Biocon has sold the shares to achieve minimum public shareholding requirement. Public shareholding was 25.90%. 

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Company-Dynamic
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.